The objective of the ESMO Symposium on Signalling Pathways in Cancer is to bring together basic scientists, academics, clinical researchers and industry researchers, medical and young oncologists with a special interest in the field in order to facilitate knowledge sharing through a series of interactive sessions and workshops.
The focus of the Symposium is on the preclinical and clinical issues relevant for targeting DNA damage response and the effect of systemic and radiation therapies.
The 5th Symposium – focusing on DNA damage response – was held in partnership with EACR.
ESMO Scientific Co-Chair
Ruth Plummer, Newcastle upon Tyne, UK
EACR Scientific Co-Chair
Eli Pikarsky, Jerusalem, Israel
Fortunato Ciardiello, Naples, Italy
Thomas Helleday, Stockholm, Sweden
Clare Isacke, London, UK
Jos Jonkers, Amsterdam, Netherlands